0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessNCT02325739 .
Stephen L. Chan, Martin Schüler, Yoon‐Koo Kang, Chia‐Jui Yen, Julien Edeline, Su Pin Choo, Chia‐Chi Lin, Takuji Okusaka, Karl-Heinz Weiss, Teresa Macarulla, Stéphane Cattan, Jean–Frédéric Blanc, Kyung-Hun Lee, Michela Maur, Shubham Pant, Masatoshi Kudo, Éric Assenat, Andrew X. Zhu, Thomas Yau, Ho Yeong Lim, Jordi Bruix, Andreas Geier, Carmen Guillén‐Ponce, Angelica Fasolo, Richard S. Finn, Jia Fan, Arndt Vogel, Shukui Qin, Markus Riester, Vasiliki Katsanou, Monica Chaudhari, Tomoyuki Kakizume, Yi Gu, Diana Graus Porta, Andrea P. Myers, Jean‐Pierre Delord (2022). A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors. , 41(1), DOI: https://doi.org/10.1186/s13046-022-02383-5.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2022
Authors
36
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1186/s13046-022-02383-5
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
